The effect of pancreatic islet transplantation on progression of diabetic retinopathy and neuropathy

T. C. Lee, N. R. Barshes, C. A. O'Mahony, L. Nguyen, F. C. Brunicardi, Camillo Ricordi, Rodolfo Alejandro, A. P. Schock, A. Mote, J. A. Goss

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

Introduction. Pancreatic islet transplantation (PIT) has only become an effective treatment for type 1 diabetes mellitus within the past 4 years. As a result, the long-term effects of PIT on progression of diabetic neuropathy and retinopathy are unknown. The benefit of halting or improving diabetic neuropathy and retinopathy is of particular interest since most PIT recipients have not developed the advanced complications of diabetes. Herein, we describe the improvement and stabilization of diabetic neuropathy and retinopathy in 12 PIT recipients. Patients and methods. Between January 1, 2002, and June 30, 2004, there have been 12 patients who have received PIT. Currently, there are eight patients who have sufficient follow-up to assess the progression of diabetic retinopathy and neuropathy. To assess for disease progression, patients were examined by a single ophthalmologist and single neurologist throughout the study period. Eye exams were performed using a slit-lamp exam while neurological status was assessed using electromyelograms and clinical exams. Results. All PIT recipients had decreases in hemoglobin A1C and increases in serum C-peptide. All study patients had stabilization of their retinopathic disease. One patient demonstrated improvement of retinopathy at 1 year posttransplant. Fifty percent of patients demonstrated improvement or stabilization of their diabetic neuropathy. One patient had mild reinnervation of the fingers and wrist extensors by clinical exam 1 year posttransplant. Four patients exhibited an average decrease of 19% in sural nerve conduction velocities. Conclusion. Our series has demonstrated that all PIT recipients have had stabilization of their diabetic retinopathy and that 50% of patients exhibited stabilization or even improvement of their diabetic neuropathy.

Original languageEnglish
Pages (from-to)2263-2265
Number of pages3
JournalTransplantation Proceedings
Volume37
Issue number5
DOIs
StatePublished - Jun 1 2005

Fingerprint

Islets of Langerhans Transplantation
Diabetic Neuropathies
Diabetic Retinopathy
Sural Nerve
C-Peptide
Neural Conduction
Diabetes Complications
Wrist
Type 1 Diabetes Mellitus
Fingers
Disease Progression
Hemoglobins

ASJC Scopus subject areas

  • Surgery
  • Transplantation

Cite this

The effect of pancreatic islet transplantation on progression of diabetic retinopathy and neuropathy. / Lee, T. C.; Barshes, N. R.; O'Mahony, C. A.; Nguyen, L.; Brunicardi, F. C.; Ricordi, Camillo; Alejandro, Rodolfo; Schock, A. P.; Mote, A.; Goss, J. A.

In: Transplantation Proceedings, Vol. 37, No. 5, 01.06.2005, p. 2263-2265.

Research output: Contribution to journalArticle

Lee, TC, Barshes, NR, O'Mahony, CA, Nguyen, L, Brunicardi, FC, Ricordi, C, Alejandro, R, Schock, AP, Mote, A & Goss, JA 2005, 'The effect of pancreatic islet transplantation on progression of diabetic retinopathy and neuropathy', Transplantation Proceedings, vol. 37, no. 5, pp. 2263-2265. https://doi.org/10.1016/j.transproceed.2005.03.011
Lee, T. C. ; Barshes, N. R. ; O'Mahony, C. A. ; Nguyen, L. ; Brunicardi, F. C. ; Ricordi, Camillo ; Alejandro, Rodolfo ; Schock, A. P. ; Mote, A. ; Goss, J. A. / The effect of pancreatic islet transplantation on progression of diabetic retinopathy and neuropathy. In: Transplantation Proceedings. 2005 ; Vol. 37, No. 5. pp. 2263-2265.
@article{5285805237414487b9929d0cd777bd4a,
title = "The effect of pancreatic islet transplantation on progression of diabetic retinopathy and neuropathy",
abstract = "Introduction. Pancreatic islet transplantation (PIT) has only become an effective treatment for type 1 diabetes mellitus within the past 4 years. As a result, the long-term effects of PIT on progression of diabetic neuropathy and retinopathy are unknown. The benefit of halting or improving diabetic neuropathy and retinopathy is of particular interest since most PIT recipients have not developed the advanced complications of diabetes. Herein, we describe the improvement and stabilization of diabetic neuropathy and retinopathy in 12 PIT recipients. Patients and methods. Between January 1, 2002, and June 30, 2004, there have been 12 patients who have received PIT. Currently, there are eight patients who have sufficient follow-up to assess the progression of diabetic retinopathy and neuropathy. To assess for disease progression, patients were examined by a single ophthalmologist and single neurologist throughout the study period. Eye exams were performed using a slit-lamp exam while neurological status was assessed using electromyelograms and clinical exams. Results. All PIT recipients had decreases in hemoglobin A1C and increases in serum C-peptide. All study patients had stabilization of their retinopathic disease. One patient demonstrated improvement of retinopathy at 1 year posttransplant. Fifty percent of patients demonstrated improvement or stabilization of their diabetic neuropathy. One patient had mild reinnervation of the fingers and wrist extensors by clinical exam 1 year posttransplant. Four patients exhibited an average decrease of 19{\%} in sural nerve conduction velocities. Conclusion. Our series has demonstrated that all PIT recipients have had stabilization of their diabetic retinopathy and that 50{\%} of patients exhibited stabilization or even improvement of their diabetic neuropathy.",
author = "Lee, {T. C.} and Barshes, {N. R.} and O'Mahony, {C. A.} and L. Nguyen and Brunicardi, {F. C.} and Camillo Ricordi and Rodolfo Alejandro and Schock, {A. P.} and A. Mote and Goss, {J. A.}",
year = "2005",
month = "6",
day = "1",
doi = "10.1016/j.transproceed.2005.03.011",
language = "English",
volume = "37",
pages = "2263--2265",
journal = "Transplantation Proceedings",
issn = "0041-1345",
publisher = "Elsevier USA",
number = "5",

}

TY - JOUR

T1 - The effect of pancreatic islet transplantation on progression of diabetic retinopathy and neuropathy

AU - Lee, T. C.

AU - Barshes, N. R.

AU - O'Mahony, C. A.

AU - Nguyen, L.

AU - Brunicardi, F. C.

AU - Ricordi, Camillo

AU - Alejandro, Rodolfo

AU - Schock, A. P.

AU - Mote, A.

AU - Goss, J. A.

PY - 2005/6/1

Y1 - 2005/6/1

N2 - Introduction. Pancreatic islet transplantation (PIT) has only become an effective treatment for type 1 diabetes mellitus within the past 4 years. As a result, the long-term effects of PIT on progression of diabetic neuropathy and retinopathy are unknown. The benefit of halting or improving diabetic neuropathy and retinopathy is of particular interest since most PIT recipients have not developed the advanced complications of diabetes. Herein, we describe the improvement and stabilization of diabetic neuropathy and retinopathy in 12 PIT recipients. Patients and methods. Between January 1, 2002, and June 30, 2004, there have been 12 patients who have received PIT. Currently, there are eight patients who have sufficient follow-up to assess the progression of diabetic retinopathy and neuropathy. To assess for disease progression, patients were examined by a single ophthalmologist and single neurologist throughout the study period. Eye exams were performed using a slit-lamp exam while neurological status was assessed using electromyelograms and clinical exams. Results. All PIT recipients had decreases in hemoglobin A1C and increases in serum C-peptide. All study patients had stabilization of their retinopathic disease. One patient demonstrated improvement of retinopathy at 1 year posttransplant. Fifty percent of patients demonstrated improvement or stabilization of their diabetic neuropathy. One patient had mild reinnervation of the fingers and wrist extensors by clinical exam 1 year posttransplant. Four patients exhibited an average decrease of 19% in sural nerve conduction velocities. Conclusion. Our series has demonstrated that all PIT recipients have had stabilization of their diabetic retinopathy and that 50% of patients exhibited stabilization or even improvement of their diabetic neuropathy.

AB - Introduction. Pancreatic islet transplantation (PIT) has only become an effective treatment for type 1 diabetes mellitus within the past 4 years. As a result, the long-term effects of PIT on progression of diabetic neuropathy and retinopathy are unknown. The benefit of halting or improving diabetic neuropathy and retinopathy is of particular interest since most PIT recipients have not developed the advanced complications of diabetes. Herein, we describe the improvement and stabilization of diabetic neuropathy and retinopathy in 12 PIT recipients. Patients and methods. Between January 1, 2002, and June 30, 2004, there have been 12 patients who have received PIT. Currently, there are eight patients who have sufficient follow-up to assess the progression of diabetic retinopathy and neuropathy. To assess for disease progression, patients were examined by a single ophthalmologist and single neurologist throughout the study period. Eye exams were performed using a slit-lamp exam while neurological status was assessed using electromyelograms and clinical exams. Results. All PIT recipients had decreases in hemoglobin A1C and increases in serum C-peptide. All study patients had stabilization of their retinopathic disease. One patient demonstrated improvement of retinopathy at 1 year posttransplant. Fifty percent of patients demonstrated improvement or stabilization of their diabetic neuropathy. One patient had mild reinnervation of the fingers and wrist extensors by clinical exam 1 year posttransplant. Four patients exhibited an average decrease of 19% in sural nerve conduction velocities. Conclusion. Our series has demonstrated that all PIT recipients have had stabilization of their diabetic retinopathy and that 50% of patients exhibited stabilization or even improvement of their diabetic neuropathy.

UR - http://www.scopus.com/inward/record.url?scp=21844474811&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=21844474811&partnerID=8YFLogxK

U2 - 10.1016/j.transproceed.2005.03.011

DO - 10.1016/j.transproceed.2005.03.011

M3 - Article

C2 - 15964394

AN - SCOPUS:21844474811

VL - 37

SP - 2263

EP - 2265

JO - Transplantation Proceedings

JF - Transplantation Proceedings

SN - 0041-1345

IS - 5

ER -